Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125558051 | 12555805 | 1 | I | 20160107 | 20160701 | 20160714 | 20160714 | EXP | GB-TEVA-674242ACC | TEVA | 63.00 | YR | F | Y | 0.00000 | 20160714 | MD | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125558051 | 12555805 | 1 | PS | HALOPERIDOL. | HALOPERIDOL | 1 | Unknown | U | U | 71617 | |||||||||
125558051 | 12555805 | 2 | SS | CLOZARIL | CLOZAPINE | 1 | Oral | UNK | U | 0 | TABLET | ||||||||
125558051 | 12555805 | 3 | SS | HALDOL | HALOPERIDOL | 1 | Unknown | U | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125558051 | 12555805 | 1 | Product used for unknown indication |
125558051 | 12555805 | 2 | Schizoaffective disorder |
125558051 | 12555805 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125558051 | 12555805 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125558051 | 12555805 | Blood test abnormal | |
125558051 | 12555805 | Delusion | |
125558051 | 12555805 | Mood altered |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |